Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Gaëlle Dosne

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|December 19, 2015
A strategy for residual error modeling incorporating scedasticity of variance and distribution shapeAnne-Gaëlle Dosne, Martin Bergstrand, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|October 13, 2016
dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrapAnne-Gaëlle Dosne, Ronald Niebecker, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|September 10, 2017
An automated sampling importance resampling procedure for estimating parameter uncertaintyAnne-Gaëlle Dosne, Martin Bergstrand, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|October 13, 2016
Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resamplingAnne-Gaëlle Dosne, Martin Bergstrand, Kajsa Harling, et al.
Clinical Pharmacokinetics|April 6, 2023
Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple MyelomaXia Li, Anne-Gaëlle Dosne, Carlos Pérez Ruixo, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2025
Establishing the Exposure-QT Relationship During Bedaquiline Treatment Using a Time-Varying Tuberculosis-Specific Correction Factor (QTcTBT)Thanakorn Vongjarudech, Anne-Gaëlle Dosne, Bart Remmerie, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2022
Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated-Hepatitis B Virus-Infected MiceLouis Sandra, Huybrecht T'jollyn, Nele Goeyvaerts, et al.
Clinical Pharmacokinetics|June 23, 2021
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial HypertensionRoberta Bartolucci, Anne-Gaëlle Dosne, Dénes Csonka, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2019
Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure-QTc in patients with advanced or refractory solid tumorsElodie Valade, Anne-Gaëlle Dosne, Hong Xie, et al.
Clinical Pharmacology in Drug Development|May 13, 2024
Effect of Carbamazepine on the Pharmacokinetics of Erdafitinib in Healthy ParticipantsPharavee Jaiprasart, Peter Hellemans, Juhui James Jiao, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|December 19, 2015
A strategy for residual error modeling incorporating scedasticity of variance and distribution shapeAnne-Gaëlle Dosne, Martin Bergstrand, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|October 13, 2016
dOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrapAnne-Gaëlle Dosne, Ronald Niebecker, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|September 10, 2017
An automated sampling importance resampling procedure for estimating parameter uncertaintyAnne-Gaëlle Dosne, Martin Bergstrand, Mats O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|October 13, 2016
Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resamplingAnne-Gaëlle Dosne, Martin Bergstrand, Kajsa Harling, et al.
Clinical Pharmacokinetics|April 6, 2023
Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple MyelomaXia Li, Anne-Gaëlle Dosne, Carlos Pérez Ruixo, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 15, 2025
Establishing the Exposure-QT Relationship During Bedaquiline Treatment Using a Time-Varying Tuberculosis-Specific Correction Factor (QTcTBT)Thanakorn Vongjarudech, Anne-Gaëlle Dosne, Bart Remmerie, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2022
Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated-Hepatitis B Virus-Infected MiceLouis Sandra, Huybrecht T'jollyn, Nele Goeyvaerts, et al.
Clinical Pharmacokinetics|June 23, 2021
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial HypertensionRoberta Bartolucci, Anne-Gaëlle Dosne, Dénes Csonka, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2019
Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure-QTc in patients with advanced or refractory solid tumorsElodie Valade, Anne-Gaëlle Dosne, Hong Xie, et al.
Clinical Pharmacology in Drug Development|May 13, 2024
Effect of Carbamazepine on the Pharmacokinetics of Erdafitinib in Healthy ParticipantsPharavee Jaiprasart, Peter Hellemans, Juhui James Jiao, et al.
Pageof 2